TruBridge Inc

Aktienanalyse zu TruBridge Inc (TBRG)

$26.240

0.000 (0.00%)Zum Schluss

Loading chart…
High
26.250
Open
26.240
VWAP
26.24
Vol
302.53K
Mkt Cap
Low
26.240
Amount
7.94M
EV/EBITDA, TTM
8.67

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.

trubridge.com

AI analysis of TruBridge Inc (TBRG)

hold

TruBridge Inc (TBRG) is not a strong buy at the moment given the investor's long-term focus and beginner level. The stock is trading near its acquisition price of $26.25, limiting upside potential. Additionally, ongoing legal investigations and lack of significant growth catalysts make it a less attractive investment opportunity.

Bewertungskennzahlen

The current forward P/E ratio for TruBridge Inc (TBRG) is 9.94, compared to its 5-year average forward P/E of 11.52.

Forward P/E

Fair
5Y Average P/E
11.52
Current P/E
9.94
Überbewertet
14.41
Unterbewertet
8.64

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.35
Current EV/EBITDA
8.67
Überbewertet
9.92
Unterbewertet
6.78

Forward P/S

Fair
5Y Average P/S
0.96
Current P/S
1.06
Überbewertet
1.33
Unterbewertet
0.59

Alphio AI Price Scenarios for TBRG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%TBRG

$29.94

Szenariopreis

B

Base

Base · 50%TBRG

$26.52

Szenariopreis

B

Bear

Bear · 25%TBRG

$23.25

Szenariopreis

Whales holding TBRG

P

Paradigm Capital Management, Inc.

+ HoldingTBRG

-14.65%

3M Return

Event-Zeitleiste

2026-05-08 (ET)

16:10:00

TruBridge Reports Q1 Revenue of $86.3M

2026-04-27 (ET)

08:40:00

Deutsche Bank Raises TruBridge Price Target to $26.25

2026-04-24 (ET)

08:30:00

BMO Raises TruBridge Price Target to $26.25

07:30:00

Freedom Capital Downgrades TruBridge to Hold with $26.25 Price Target

2026-04-23 (ET)

10:20:00

TruBridge Resumes, Up 12% After IKS Health Takeover Agreement

News

TBRG FAQ — answered by Alphio AI

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations. It operates in the Healthcare sector (COMPUTER PROGRAMMING SERVICES industry).

TruBridge Inc (TBRG) is not a strong buy at the moment given the investor's long-term focus and beginner level. The stock is trading near its acquisition price of $26.25, limiting upside potential. Additionally, ongoing legal investigations and lack of significant growth catalysts make it a less attractive investment opportunity.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten